Trials / Withdrawn
WithdrawnNCT04670653
Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
National, Multicenter, Randomized, Simple-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis in Participants With Age Greater Than or Equal to 12 Years.
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Magnólia nasal gel in the treatment of moderate-severe persistent or moderate-severe intermittent allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MAGNÓLIA NASAL GEL | Magnólia nasal gel spray |
| DRUG | MOMETASONE FUROATE | Mometasone furoate nasal spray |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2023-07-01
- Completion
- 2023-10-01
- First posted
- 2020-12-17
- Last updated
- 2022-08-05
Source: ClinicalTrials.gov record NCT04670653. Inclusion in this directory is not an endorsement.